Cell Therapy and Cell Engineering Facility
Overview
Agnès Viale
Interim Co-Director
Kevin J. Curran
Interim Co-Director
Xiuyan Wang
Associate Director
The Cell Therapy and Cell Engineering Facility develops, validates, and implements procedures critical to gene transfer-related clinical research at Memorial Sloan Kettering. The quality assurance and quality control unit (QA/QC) is essential for providing a laboratory environment compliant with NIH and FDA guidelines.
Featured News
Testing CRISPR-Edited CAR T Cell Therapy in Lymphoma Clinical Trial
A groundbreaking clinical trial is testing CAR T cells created using CRISPR gene-editing technology.
Feature
Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy
An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.
Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
People
Members
Research Assistant
Research Assistant
Quality Control Assistant
Client Tech Specialist
Senior Research Assistant
Quality Assurance Specialist
Senior Research Specialist
Laboratory Quality Assurance Coordinator
Alumni
Research Assistant
Research Assistant
Senior Research Technician
Quality Assurance Manager
Research Assistant
Secretary
Senior Research QC Lab Technician
